Sensitivity analysis in economic evaluation: an audit of NICE current practice and a review of its use and value in decision-making.
暂无分享,去创建一个
P Barton | P. Barton | S Bryan | S. Bryan | L Andronis | L. Andronis | Pelham Barton | Stirling Bryan | Lazaros Andronis
[1] C. Normand,et al. Screening for sickle cell disease and thalassaemia: a systematic review with supplementary research. , 2000, Health technology assessment.
[2] J Lipscomb,et al. Assessing Uncertainty in Cost-Effectiveness Analyses , 1997, Medical decision making : an international journal of the Society for Medical Decision Making.
[3] Simon Finfer,et al. SAFE (The Saline versus Albumin Fluid Evaluation) 試験 , 2006 .
[4] M. Sculpher,et al. Decision Modelling for Health Economic Evaluation , 2006 .
[5] M. Smith,et al. Systematic review of endoscopic ultrasound in gastro-oesophageal cancer. , 1998, Health Technology Assessment.
[6] M. Pitt,et al. Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in children under the age of 12 years. , 2008, Health technology assessment.
[7] J Chilcott,et al. A review of the clinical effectiveness and cost-effectiveness of routine anti-D prophylaxis for pregnant women who are rhesus-negative. , 2003, Health technology assessment.
[8] D. Jayne. Stapled haemorrhoidopexy for the treatment of haemorrhoids. , 2009, Gastroenterologie clinique et biologique.
[9] S. Bryan,et al. Fludarabine as second-line therapy for B cell chronic lymphocytic leukaemia: a technology assessment. , 2002, Health technology assessment.
[10] K Tolley,et al. The effectiveness of domiciliary health visiting: a systematic review of international studies and a selective review of the British literature. , 2000, Health technology assessment.
[11] P Barton,et al. Cervical screening programmes: can automation help? Evidence from systematic reviews, an economic analysis and a simulation modelling exercise applied to the UK. , 2005, Health technology assessment.
[12] D G Altman,et al. Indirect comparisons of competing interventions. , 2005, Health technology assessment.
[13] N. Waugh,et al. Screening for gestational diabetes: a systematic review and economic evaluation. , 2002, Health technology assessment.
[14] K. Jolly,et al. Coronary artery stents in the treatment of ischaemic heart disease: a rapid and systematic review. , 2000, Health technology assessment.
[15] C. Czoski-Murray,et al. Extended scope of nursing practice: a multicentre randomised controlled trial of appropriately trained nurses and pre-registration house officers in pre-operative assessment in elective general surgery. , 2001, Health technology assessment.
[16] P Wainwright,et al. Virtual outreach: a randomised controlled trial and economic evaluation of joint teleconferenced medical consultations. , 2004, Health technology assessment.
[17] J Gabbay,et al. 'Early warning systems' for identifying new healthcare technologies. , 1999, Health technology assessment.
[18] David R. Jones,et al. A systematic review and evaluation of the use of tumour markers in paediatric oncology: Ewing's sarcoma and neuroblastoma. , 2003, Health technology assessment.
[19] Stirling Bryan,et al. Seeing the NICE side of cost-effectiveness analysis: a qualitative investigation of the use of CEA in NICE technology appraisals. , 2007, Health economics.
[20] J. Fox-Rushby,et al. Allowing for uncertainty in economic evaluations: qualitative sensitivity analysis. , 2001, Health policy and planning.
[21] P. Royle,et al. Screening for hepatitis C among injecting drug users and in genitourinary medicine clinics: systematic reviews of effectiveness, modelling study and national survey of current practice. , 2002, Health technology assessment.
[22] David Parkin,et al. Does NICE have a cost-effectiveness threshold and what other factors influence its decisions? A binary choice analysis. , 2004, Health economics.
[23] J. Dretzke,et al. Autoantibody testing in children with newly diagnosed type 1 diabetes mellitus. , 2004, Health technology assessment.
[24] M. Sculpher,et al. Making decisions under uncertainty--the role of probabilistic decision modelling. , 2006, Family practice.
[25] P Sutcliffe,et al. Health technology assessment. , 1986, Israel journal of medical sciences.
[26] M K Campbell,et al. Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement. , 2004, Health technology assessment.
[27] E Berry,et al. The cost-effectiveness of magnetic resonance angiography for carotid artery stenosis and peripheral vascular disease: a systematic review. , 2002, Health technology assessment.
[28] D. Symmons,et al. A comparison of the cost-effectiveness of five strategies for the prevention of non-steroidal anti-inflammatory drug-induced gastrointestinal toxicity: a systematic review with economic modelling. , 2006, Health technology assessment.
[29] M Knapp,et al. Measurement of health-related quality of life for people with dementia: development of a new instrument (DEMQOL) and an evaluation of current methodology. , 2005, Health technology assessment.
[30] A Haycox,et al. Coronary artery stents: a rapid systematic review and economic evaluation. , 2004, Health technology assessment.
[31] N. Waugh,et al. Combination therapy (interferon alfa and ribavirin) in the treatment of chronic hepatitis C: a rapid and systematic review. , 2000, Health technology assessment.
[32] C. Bull,et al. Newborn screening for congenital heart defects: a systematic review and cost-effectiveness analysis. , 2005, Health technology assessment.
[33] M. McDonagh,et al. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of glycoprotein IIb/IIIa antagonists in the medical management of unstable angina. , 2000, Health technology assessment.
[34] S. Paisley,et al. Psychological therapies including dialectical behaviour therapy for borderline personality disorder: a systematic review and preliminary economic evaluation. , 2006, Health technology assessment.
[35] M. Sculpher,et al. Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra. , 2005, Health economics.
[36] A. Silman,et al. Supplementation of a home-based exercise programme with a class-based programme for people with osteoarthritis of the knees: a randomised controlled trial and health economic analysis. , 2004, Health technology assessment.
[37] A. Culyer,et al. Effectiveness and efficiency of methods of dialysis therapy for end-stage renal disease: systematic reviews. , 1998, Health technology assessment.
[38] T. Sheldon,et al. What role for statins? A review and economic model. , 1999, Health technology assessment.
[39] P. Barry,et al. Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature. , 2001, Health technology assessment.
[40] C. Beverley,et al. Clinical and cost-effectiveness of electroconvulsive therapy for depressive illness, schizophrenia, catatonia and mania: systematic reviews and economic modelling studies. , 2005, Health technology assessment.
[41] K E Willard,et al. Probabilistic Analysis of Decision Trees Using Monte Carlo Simulation , 1986, Medical decision making : an international journal of the Society for Medical Decision Making.
[42] Bas Groot Koerkamp,et al. Limitations of Acceptability Curves for Presenting Uncertainty in Cost-Effectiveness Analysis , 2007, Medical decision making : an international journal of the Society for Medical Decision Making.
[43] A. Glenny,et al. Antimicrobial prophylaxis in colorectal surgery: a systematic review of randomized controlled trials , 1998, Health technology assessment.
[44] R. Milne,et al. Disease-modifying drugs for multiple sclerosis: a rapid and systematic review. , 2000, Health technology assessment.
[45] J Gabbay,et al. Involving consumers in research and development agenda setting for the NHS: developing an evidence-based approach. , 2004, Health technology assessment.
[46] F. Song,et al. Evaluating non-randomised intervention studies. , 2003, Health technology assessment.
[47] S. Paisley,et al. Clinical and cost-effectiveness of new and emerging technologies for early localised prostate cancer: a systematic review. , 2003, Health technology assessment.
[48] P. Royle,et al. Literature searching for clinical and cost-effectiveness studies used in health technology assessment reports carried out for the National Institute for Clinical Excellence appraisal system. , 2003, Health technology assessment.
[49] M. Mugford,et al. The Social Support and Family Health Study: a randomised controlled trial and economic evaluation of two alternative forms of postnatal support for mothers living in disadvantaged inner-city areas. , 2004, Health technology assessment.
[50] M. Drummond,et al. Health Care Technology: Effectiveness, Efficiency and Public Policy@@@Methods for the Economic Evaluation of Health Care Programmes , 1988 .
[51] C Fraser,et al. Laparoscopic surgery for inguinal hernia repair: systematic review of effectiveness and economic evaluation. , 2005, Health technology assessment.
[52] M Sculpher,et al. Clopidogrel used in combination with aspirin compared with aspirin alone in the treatment of non-ST-segment-elevation acute coronary syndromes: a systematic review and economic evaluation. , 2004, Health technology assessment.
[53] A. Briggs,et al. Cost-Effectiveness Acceptability Curves in the Dock , 2007, Medical decision making : an international journal of the Society for Medical Decision Making.
[54] Gordon B. Hazen,et al. Sensitivity Analysis and the Expected Value of Perfect Information , 1998, Medical decision making : an international journal of the Society for Medical Decision Making.
[55] F A Sonnenberg,et al. Toward a Peer Review Process for Medical Decision Analysis Models , 1994, Medical care.
[56] N. Waugh,et al. Pegylated interferon alpha-2a and -2b in combination with ribavirin in the treatment of chronic hepatitis C: a systematic review and economic evaluation. , 2004, Health technology assessment.
[57] P. Whiting,et al. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of debriding agents in treating surgical wounds healing by secondary intention. , 2001, Health technology assessment.
[58] David R. Jones,et al. Methods for the analysis of quality-of-life and survival data in health technology assessment. , 1999, Health technology assessment.
[59] Karl Claxton,et al. Probabilistic analysis and computationally expensive models: Necessary and required? , 2006, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[60] T O Jefferson,et al. Guidelines for authors and peer reviewers of economic submissions to the BMJ , 1996, BMJ.
[61] A. Culyer,et al. False-negative results in screening programmes: systematic review of impact and implications. , 2000, Health technology assessment.
[62] S. Mason,et al. EVALUATE hysterectomy trial: a multicentre randomised trial comparing abdominal, vaginal and laparoscopic methods of hysterectomy. , 2004, Health technology assessment.
[63] S. Palmer,et al. Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation. , 2006, Health Technology Assessment.
[64] J Cowan,et al. Clinical and cost-effectiveness of capecitabine and tegafur with uracil for the treatment of metastatic colorectal cancer: systematic review and economic evaluation. , 2003, Health technology assessment.
[65] C. Longson,et al. Cardiac resynchronisation therapy for the treatment of heart failure: NICE technology appraisal guidance , 2007, Heart.
[66] M Sculpher,et al. A rapid and systematic review and economic evaluation of the clinical and cost-effectiveness of newer drugs for treatment of mania associated with bipolar affective disorder. , 2004, Health technology assessment.
[67] B. Cooper,et al. Systematic review of isolation policies in the hospital management of methicillin-resistant Staphylococcus aureus: a review of the literature with epidemiological and economic modelling. , 2003, Health technology assessment.
[68] M Sculpher,et al. Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation. , 2005, Health technology assessment.
[69] H. Gravelle,et al. Discounting for health effects in cost-benefit and cost-effectiveness analysis. , 2001, Health economics.
[70] K Claxton,et al. The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies. , 1999, Journal of health economics.
[71] C. Eiser,et al. Quality-of-life measures in chronic diseases of childhood. , 2001, Health technology assessment.
[72] M. Pitt,et al. The effectiveness and cost-effectiveness of dual-chamber pacemakers compared with single-chamber pacemakers for bradycardia due to atrioventricular block or sick sinus syndrome: systematic review and economic evaluation. , 2005, Health technology assessment.
[73] M. Gulliford,et al. Monitoring blood glucose control in diabetes mellitus: a systematic review. , 2000, Health technology assessment.
[74] D. Symmons,et al. The British Rheumatoid Outcome Study Group (BROSG) randomised controlled trial to compare the effectiveness and cost-effectiveness of aggressive versus symptomatic therapy in established rheumatoid arthritis. , 2005, Health technology assessment.
[75] R. Murray,et al. Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment. , 2006, Health technology assessment.
[76] R. Fitzpatrick,et al. Issues in methodological research: perspectives from researchers and commissioners. , 2001, Health technology assessment.
[77] A. Grant,et al. Improving the referral process for familial breast cancer genetic counselling: findings of three randomised controlled trials of two interventions. , 2005, Health technology assessment.
[78] T. Skinner,et al. Effects of educational and psychosocial interventions for adolescents with diabetes mellitus: a systematic review. , 2001, Health technology assessment.
[79] J. Lord,et al. Estimating uncertainty ranges for costs by the bootstrap procedure combined with probabilistic sensitivity analysis. , 1999, Health economics.
[80] A Briggs,et al. Uncertainty in the economic evaluation of health care technologies: the role of sensitivity analysis. , 1994, Health economics.
[81] D. Lamping,et al. An evaluation of the costs, effectiveness and quality of renal replacement therapy provision in renal satellite units in England and Wales. , 2005, Health technology assessment.
[82] F. Cowan,et al. Implantable contraceptives (subdermal implants and hormonally impregnated intrauterine systems) versus other forms of reversible contraceptives: two systematic reviews to assess relative effectiveness, acceptability, tolerability and cost-effectiveness. , 2000, Health technology assessment.
[83] J. Heyse,et al. Use of an angular transformation for ratio estimation in cost-effectiveness analysis. , 2000, Statistics in medicine.
[84] M. Sculpher,et al. Is hydrotherapy cost-effective? A randomised controlled trial of combined hydrotherapy programmes compared with physiotherapy land techniques in children with juvenile idiopathic arthritis. , 2005, Health technology assessment.
[85] S. Walters,et al. Costs and benefits of community postnatal support workers: a randomised controlled trial. , 2000, Health technology assessment.
[86] J Raftery,et al. Clinical and cost-effectiveness of newer immunosuppressive regimens in renal transplantation: a systematic review and modelling study. , 2005, Health technology assessment.
[87] T P Klassen,et al. The inclusion of reports of randomised trials published in languages other than English in systematic reviews. , 2003, Health technology assessment.
[88] A. Culyer,et al. Liquid-based cytology in cervical screening: a rapid and systematic review. , 2000, Health technology assessment.
[89] E. Murphy,et al. Qualitative research methods in health technology assessment: a review of the literature. , 1998, Health technology assessment.
[90] Andrew Briggs,et al. Probabilistic analysis of cost-effectiveness models: statistical representation of parameter uncertainty. , 2005, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[91] G. ter Riet,et al. Methods of prediction and prevention of pre-eclampsia: systematic reviews of accuracy and effectiveness literature with economic modelling. , 2008, Health technology assessment.
[92] J. Wight,et al. Treatments for spasticity and pain in multiple sclerosis: a systematic review. , 2003, Health technology assessment.
[93] Jennifer A. Roberts,et al. Health benefits of antiviral therapy for mild chronic hepatitis C: randomised controlled trial and economic evaluation. , 2006, Health technology assessment.
[94] Stirling Bryan,et al. Modelling in the economic evaluation of health care: selecting the appropriate approach , 2004, Journal of health services research & policy.
[95] R Garside,et al. The effectiveness and cost-effectiveness of pimecrolimus and tacrolimus for atopic eczema: a systematic review and economic evaluation. , 2005, Health technology assessment.
[96] A. Bagnall,et al. Effectiveness and cost-effectiveness of acute hospital-based spinal cord injuries services: systematic review. , 2003, Health technology assessment.
[97] M. Knapp,et al. Home treatment for mental health problems: a systematic review. , 2001, Health technology assessment.
[98] J A Kanis,et al. Treatment of established osteoporosis: a systematic review and cost-utility analysis. , 2002, Health technology assessment.
[99] P F Sharp,et al. The value of digital imaging in diabetic retinopathy. , 2003, Health technology assessment.
[100] M Forshaw,et al. A critical review of the role of neonatal hearing screening in the detection of congenital hearing impairment. , 1997, Health technology assessment.
[101] M. Drummond,et al. Economic Evaluation in Health Care: Merging Theory with Practice , 2002 .
[102] A E Ades,et al. Evidence synthesis, parameter correlation and probabilistic sensitivity analysis. , 2006, Health economics.
[103] A. Grant,et al. Systematic review of the clinical effectiveness and cost-effectiveness of tension-free vaginal tape for treatment of urinary stress incontinence. , 2003, Health technology assessment.
[104] S. Wessely,et al. A systematic review of controlled trials of the effectiveness and cost-effectiveness of brief psychological treatments for depression. , 2002, Health technology assessment.
[105] K. Morgan,et al. Psychological treatment for insomnia in the regulation of long-term hypnotic drug use. , 2004, Health technology assessment.
[106] P. Bower,et al. Randomised controlled trial of non-directive counselling, cognitive-behaviour therapy and usual general practitioner care in the management of depression as well as mixed anxiety and depression in primary care. , 2000, Health technology assessment.
[107] P. Roderick,et al. The cost-effectiveness of screening for Helicobacter pylori to reduce mortality and morbidity from gastric cancer and peptic ulcer disease: a discrete-event simulation model. , 2003, Health Technology Assessment.
[108] M. Westwood,et al. Systematic review of the clinical effectiveness and cost-effectiveness of capecitabine (Xeloda) for locally advanced and/or metastatic breast cancer. , 2004, Health technology assessment.
[109] M J Buxton,et al. Evaluating patient-based outcome measures for use in clinical trials. , 1998, Health technology assessment.
[110] J Nicholl,et al. Routine preoperative testing: a systematic review of the evidence. , 1997, Health technology assessment.
[111] S. Stearns,et al. Systematic review of the effectiveness and cost-effectiveness, and economic evaluation, of home versus hospital or satellite unit haemodialysis for people with end-stage renal failure. , 2003, Health technology assessment.
[112] David R. Jones,et al. A systematic review of discharge arrangements for older people. , 2002, Health technology assessment.
[113] D. Spiegelhalter,et al. Consensus development methods, and their use in clinical guideline development. , 1998, Health technology assessment.
[114] M. Pitt,et al. Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling. , 2006, Health technology assessment.
[115] S. Ebrahim,et al. Provision, uptake and cost of cardiac rehabilitation programmes: improving services to under-represented groups. , 2004, Health technology assessment.
[116] Milton C Weinstein,et al. Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on Good Research Practices--Modeling Studies. , 2003, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[117] R. Collins,et al. Towards evidence-based guidelines for the prevention of venous thromboembolism: systematic reviews of mechanical methods, oral anticoagulation, dextran and regional anaesthesia as thromboprophylaxis. , 2005, Health technology assessment.
[118] Bernie J. O'Brien,et al. In Search of Power and Significance: Issues in the Design and Analysis of Stochastic Cost-Effectiveness Studies in Health Care , 1994, Medical care.
[119] A. Round,et al. Effectiveness and cost-effectiveness of imatinib for first-line treatment of chronic myeloid leukaemia in chronic phase: a systematic review and economic analysis. , 2004, Health technology assessment.
[120] A E Ades,et al. Antenatal and neonatal haemoglobinopathy screening in the UK: review and economic analysis. , 1999, Health technology assessment.
[121] R. Milne,et al. Clinical effectiveness and cost-effectiveness of growth hormone in children: a systematic review and economic evaluation. , 2002, Health technology assessment.
[122] A. Knowles. DIABETIC FOOT ULCERATION , 1996 .
[123] R. Milne,et al. Zanamivir for the treatment of influenza in adults: a systematic review and economic evaluation. , 2002, Health technology assessment.
[124] R. Jordan,et al. Treatments for fatigue in multiple sclerosis: a rapid and systematic review. , 2000, Health technology assessment.
[125] A. Culyer,et al. Newborn screening for inborn errors of metabolism: a systematic review. , 1997, Health technology assessment.
[126] A H Briggs,et al. Handling uncertainty when performing economic evaluation of healthcare interventions. , 1999, Health technology assessment.
[127] A. Thompson,et al. Improving the evaluation of therapeutic interventions in multiple sclerosis: development of a patient-based measure of outcome. , 2004, Health technology assessment.
[128] C. Clar,et al. Clinical and cost-effectiveness of autologous chondrocyte implantation for cartilage defects in knee joints: systematic review and economic evaluation. , 2005, Health technology assessment.
[129] Javier Soto,et al. HEALTH ECONOMIC EVALUATIONS USING DECISION ANALYTIC MODELING , 2002, International Journal of Technology Assessment in Health Care.
[130] C. Normand,et al. A systematic review of the role of bisphosphonates in metastatic disease. , 2004, Health technology assessment.
[131] M. Petticrew,et al. Resource allocation for chronic stable angina: a systematic review of effectiveness, costs and cost-effectiveness of alternative interventions. , 1998, Health technology assessment.
[132] T. Peters,et al. Subgroup analyses in randomised controlled trials: quantifying the risks of false-positives and false-negatives. , 2001, Health technology assessment.
[133] M. Mugford,et al. Ultrasound screening in pregnancy: a systematic review of the clinical effectiveness, cost-effectiveness and women's views. , 2000, Health technology assessment.
[134] C. Fowler,et al. Randomised evaluation of alternative electrosurgical modalities to treat bladder outflow obstruction in men with benign prostatic hyperplasia. , 2005, Health technology assessment.
[135] K. Payne,et al. Which anaesthetic agents are cost-effective in day surgery? Literature review, national survey of practice and randomised controlled trial. , 2002, Health technology assessment.
[136] A Haycox,et al. Early thrombolysis for the treatment of acute myocardial infarction: a systematic review and economic evaluation. , 2003, Health technology assessment.